Dermata Therapeutics (DRMAW) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-5.4
-3.76
-2.11
-0.47

Details

Expected EPS
-2.64
Actual EPS
-2.04
Surprise EPS
0.6
Surprise Percent
+22.73%

Description

Dermata Therapeutics (DRMAW) has reported earnings of -2.04 per share for Q4 2024.

0 Comments

Share your thoughts